Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in Genes Chromosomes Cancer

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    February 2021
  1. PTAKOVA N, Martinek P, Holubec L, Janovsky V, et al
    Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
    Genes Chromosomes Cancer. 2021 Feb 13. doi: 10.1002/gcc.22942.
    PubMed     Abstract available


    October 2020
  2. NIENTIEDT C, Duensing A, Zschabitz S, Jager D, et al
    PARP inhibition in prostate cancer.
    Genes Chromosomes Cancer. 2020 Oct 21. doi: 10.1002/gcc.22903.
    PubMed     Abstract available


    November 2019
  3. GUPTA S, Hovelson DH, Kemeny G, Halabi S, et al
    Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
    Genes Chromosomes Cancer. 2019 Nov 9. doi: 10.1002/gcc.22824.
    PubMed     Abstract available


    July 2019
  4. WALLANDER K, Liu W, von Holst S, Thutkawkorapin J, et al
    Genetic analyses supporting a colorectal, gastric, and prostate cancer syndrome.
    Genes Chromosomes Cancer. 2019 Jul 23. doi: 10.1002/gcc.22786.
    PubMed     Abstract available


    January 2019
  5. KLUTH M, Abdelaziz Z, Ozden C, Hussein K, et al
    5q21 deletion is often heterogeneous in prostate cancer.
    Genes Chromosomes Cancer. 2019 Jan 9. doi: 10.1002/gcc.22730.
    PubMed     Abstract available


    June 2018
  6. KLUTH M, Scherzai S, Buschek F, Fraune C, et al
    13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer.
    Genes Chromosomes Cancer. 2018 Jun 20. doi: 10.1002/gcc.22645.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: